Arcus Biosciences, Inc. (NASDAQ:NYSE:RCUS), a biopharmaceutical company focused on developing innovative cancer therapies, stands at a critical juncture in its journey to bring novel treatments to ...

HAYWARD, Calif., June 10, 2025--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and ...

HAYWARD, Calif., May 27, 2025--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and ...

Bohemia Interactive has brought the Arma experience to PlayStation today, and has launched Arma Reforger on PS5 as a surprise. You can grab it on the PlayStation Store by following the Arma ...

Last month Arcus reported top -line phase 2 results with the TIGIT drug that it said warranted taking it forward into a phase 3 programme, but so far there's no word from Gilead on a buy-in.

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...

The G7 ambassadors to Ukraine have welcomed the adoption of a law reforming the National Agency of Ukraine for Finding, Tracing and Management of Assets Derived from Corruption and Other Crimes (ARMA) ...

Now, Military Logistics Simulator, a new game that mixes Roadcraft's emphasis on vehicle transport with Arma 3's focus on realistic military equipment, has arrived to offer a new take on this ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...

Research methods and human development. Doreen Arcus, Ph.D., is interested in the social development of children and youth in the contexts of family, school and community. Her earlier studies of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...